Aclarion adds University of Arizona College of Medicine–Phoenix as CLARITY trial site for Nociscan - ACON News | RalliesAclarion adds University of Arizona College of Medicine–Phoenix as CLARITY trial site for Nociscan
A
ACON• CLARITY trial expands to new enrolling site
- Aclarion added University of Arizona College of Medicine – Phoenix as a new enrolling site for its CLARITY spine-surgery trial.
- The 300-patient, randomized study tests whether Nociscan improves outcomes in discogenic chronic low back pain surgeries.
- No results have been presented; early interim findings are expected to be publicly disclosed in Q4 2026.
- The trial aims to support broader adoption of Nociscan for surgical decision-making by improving patient selection and reducing avoidable procedures.
- Ten sites are now enrolling, expanding recruitment capacity and potentially accelerating the timeline to clinically meaningful readouts.
MDB
•
